Charts AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

Delayed Börse Stuttgart Other stock markets 15:33:53 05/10/2021 BST			5-day change	1st Jan Change
5.28 ^EUR	-0.19%		-10.02%	+20.93%

03-25	AVEO Pharmaceuticals, Inc. Announces Executive Changes	CI
02-06	Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist	CI

ProRealTime Chart